Nikolai Suslov

Nikolai Suslov is a seasoned professional in the field of antibody discovery and protein engineering, currently serving as Vice President of Antibody Discovery Programs at Alloy Therapeutics, Inc. since October 2024. Prior to this role, Nikolai held the position of Senior Director of Protein Engineering at Phenomic from June 2023 to October 2024. Experience also includes serving as Senior Principal Scientist (Lab Head) at Sanofi Genzyme from January 2021 to June 2023 and Associate Director in Biologics and Molecular Pharmacology at Rakuten Aspyrian, where contributions were made to innovative oncological therapies. Further background includes working as a Senior Scientist at Takeda California, where strategic leadership was provided in various aspects of antibody development. Nikolai’s academic credentials include a Ph.D. in Biochemistry and Molecular Biology from the University of Chicago and a B.A. in Biochemistry and Religion from Northwestern University.